Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-017064
Filing Date
2025-05-15
Accepted
2025-05-15 11:07:34
Documents
88
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20250331_10q.htm   iXBRL 10-Q 1517227
2 EXHIBIT 31.1 ex_815363.htm EX-31.1 8334
3 EXHIBIT 31.2 ex_815364.htm EX-31.2 8666
4 EXHIBIT 32.1 ex_815365.htm EX-32.1 4343
5 EXHIBIT 32.2 ex_815366.htm EX-32.2 4208
  Complete submission text file 0001437749-25-017064.txt   9397712

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nby-20250331.xsd EX-101.SCH 92297
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20250331_def.xml EX-101.DEF 626476
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20250331_lab.xml EX-101.LAB 462529
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20250331_pre.xml EX-101.PRE 662819
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20250331_cal.xml EX-101.CAL 36375
91 EXTRACTED XBRL INSTANCE DOCUMENT nby20250331_10q_htm.xml XML 1691667
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 25950040
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)